Covered recipient · General Payments record
CAROLYNE THOMAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$680.12
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $542.24 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $158.78 | 9 |
| Novo Nordisk AS | $71.81 | 4 |
| Amgen Inc. | $60.20 | 3 |
| PFIZER INC. | $47.47 | 3 |
| Lilly USA, LLC | $35.92 | 2 |
| GlaxoSmithKline, LLC. | $21.75 | 1 |
| Noven Therapeutics, LLC | $17.75 | 1 |
| Seqirus USA Inc | $17.70 | 1 |
| Esperion Therapeutics, Inc. | $17.22 | 1 |
| Merck Sharp & Dohme Corporation | $16.98 | 1 |
| Edwards Lifesciences Corporation | $16.82 | 1 |
| Axsome Therapeutics, Inc. | $16.59 | 1 |
| Exact Sciences Corporation | $15.99 | 1 |
| IBSA Pharma Inc. | $13.91 | 1 |
| Acerta Pharma LLC | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.32 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300878 | CMS |
| ABBVIE INC. | $11.97 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300880 | CMS |
| ABBVIE INC. | $18.15 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300882 | CMS |
| ABBVIE INC. | $11.13 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300884 | CMS |
| ABBVIE INC. | $10.09 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300886 | CMS |
| ABBVIE INC. | $26.42 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300888 | CMS |
| ABBVIE INC. | $17.14 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300890 | CMS |
| ABBVIE INC. | $12.10 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300892 | CMS |
| ABBVIE INC. | $25.46 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108300894 | CMS |
| Amgen Inc. | $28.08 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116176496 | CMS |
| Amgen Inc. | $16.95 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117700400 | CMS |
| Amgen Inc. | $15.17 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117700402 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.35 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104226429 | CMS |
| Axsome Therapeutics, Inc. | $16.59 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148345092 | CMS |
| Edwards Lifesciences Corporation | $16.82 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138804645 | CMS |
| Esperion Therapeutics, Inc. | $17.22 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129477566 | CMS |
| Exact Sciences Corporation | $15.99 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114930628 | CMS |
| GlaxoSmithKline, LLC. | $21.75 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116362623 | CMS |
| IBSA Pharma Inc. | $13.91 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142972257 | CMS |
| Lilly USA, LLC | $18.31 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135578680 | CMS |
| Lilly USA, LLC | $17.61 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135585802 | CMS |
| Merck Sharp & Dohme LLC | $16.98 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141692610 | CMS |
| Noven Therapeutics, LLC | $17.75 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084829088 | CMS |
| Novo Nordisk Inc | $14.61 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100535333 | CMS |
| Novo Nordisk Inc | $16.70 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100273290 | CMS |
| Novo Nordisk Inc | $21.94 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100303241 | CMS |
| Novo Nordisk Inc | $18.56 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100448971 | CMS |
| PFIZER INC. | $15.12 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131546272 | CMS |
| PFIZER INC. | $16.19 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131664079 | CMS |
| PFIZER INC. | $16.16 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131625639 | CMS |
| Seqirus USA Inc | $17.70 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125639699 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.